Goldman reiterated its Neutral rating on Athenahealth ATHN. At the same time, the rating agency raised its price target on the company's stock from $47 to $58. On Friday, ATHN closed the day at $57.09. Its shares lost 0.44% of their value in today's pre-market trading to stand around $56.84.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
